Human Intervention Studies – Atlantia Food CRO
The Alimentary Pharmabiotic Centre has recently branded its Human Intervention Studies platform as Atlantia Food CRO. This platform provides a comprehensive end-to-end solution for human intervention studies for functional ingredients in foods, nutraceuticals, medical foods, dietary supplements and infant formula.
If you have any questions or would like further information, please contact Andrea Doolan, Human Studies Manager at email@example.com; tel +353 21 4901406
Atlantia Food CRO offers a complete lifecycle range of services to food companies; for full details see www.atlantiafoodcro.com
COLONIST - the COrk LONgitudinal IBS STudy
COLONIST is a longitudinal study of Irritable Bowel Syndrome (IBS) patients to evaluate fluctuations in, and examine relationships between, disease activity, co-morbidity, immune profile and composition of the intestinal microbiota over time. Professor Eamonn Quigley is leading this study, which involves 500 healthy and IBS subjects and follows them at regular intervals over a 5 year time period. The primary objective of this study is to define, through the assembly of baseline and longitudinal data, the phenotype, immune profile, dietary intake and composition of the human intestinal microbiota of over 500 IBS sufferers and compare this to the microbiota in healthy subjects.
If you, or someone you know, suffers from IBS and would like more information about the COLONIST study, please contact Ann O’Neill at 087-9586255 or firstname.lastname@example.org.
The objective of the INFANTMET study is to define the composition and functional performance of the baseline microbiota in developing breast fed infants over time, using state-of-the-art pryo-sequencing technology. The project will deliver information on the evolving gut microbiota of infants born at Cork University Maternity Hospital over the first two years of life. Thus, the project will provide new opportunities for optimisation of infant milk formula composition, with appropriate new bioactive ingredients such as milk fractions, probiotics and prebiotics to effectively programme the early infant gut microbiota in a manner closer to mothers milk. This 4-year study is led by Teagasc, Moorepark, and involves a partnership between CORK University Maternity Hospital and University College Cork and is funded by the Irish Government Department of Agriculture, Food and the Marine.